Nuvation Bio Enrolls 1st Patient in Global Study of Safusidenib
23 Oct 2025 //
BUSINESSWIRE
Nuvation Bio Appoints Philippe Sauvage As Chief Financial Officer
07 Oct 2024 //
BUSINESSWIRE
AnHeart Announces Initiation of Global Phase 2 Trial Evaluating Safusidenib
07 Sep 2023 //
BUSINESSWIRE

Market Place
Sourcing Support